BIOkey International (BKYI)
(Delayed Data from NSDQ)
$1.41 USD
-0.01 (-0.71%)
Updated Aug 7, 2024 03:59 PM ET
After-Market: $1.42 +0.01 (0.71%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BKYI 1.41 -0.01(-0.71%)
Will BKYI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BKYI based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BKYI
One new option listing and eighteen option delistings on July 22nd
Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics
BIO-key Secures Los Angeles LGBT Center's IT Systems with Seamless Badge-Tap Authentication Solution
BIO-key says Los Angeles LGBT Center selects PortalGuard plaform
BIO-key International Inc (BKYI) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue ...